全文获取类型
收费全文 | 3601篇 |
免费 | 205篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 137篇 |
妇产科学 | 67篇 |
基础医学 | 556篇 |
口腔科学 | 76篇 |
临床医学 | 266篇 |
内科学 | 886篇 |
皮肤病学 | 99篇 |
神经病学 | 335篇 |
特种医学 | 48篇 |
外科学 | 305篇 |
综合类 | 29篇 |
一般理论 | 1篇 |
预防医学 | 157篇 |
眼科学 | 191篇 |
药学 | 309篇 |
中国医学 | 30篇 |
肿瘤学 | 292篇 |
出版年
2024年 | 3篇 |
2023年 | 40篇 |
2022年 | 66篇 |
2021年 | 98篇 |
2020年 | 31篇 |
2019年 | 73篇 |
2018年 | 86篇 |
2017年 | 68篇 |
2016年 | 93篇 |
2015年 | 89篇 |
2014年 | 107篇 |
2013年 | 141篇 |
2012年 | 211篇 |
2011年 | 277篇 |
2010年 | 149篇 |
2009年 | 134篇 |
2008年 | 248篇 |
2007年 | 283篇 |
2006年 | 244篇 |
2005年 | 267篇 |
2004年 | 247篇 |
2003年 | 228篇 |
2002年 | 224篇 |
2001年 | 26篇 |
2000年 | 19篇 |
1999年 | 35篇 |
1998年 | 40篇 |
1997年 | 38篇 |
1996年 | 36篇 |
1995年 | 27篇 |
1994年 | 26篇 |
1993年 | 17篇 |
1992年 | 15篇 |
1991年 | 16篇 |
1990年 | 11篇 |
1989年 | 14篇 |
1988年 | 5篇 |
1987年 | 9篇 |
1986年 | 8篇 |
1985年 | 7篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1974年 | 3篇 |
1956年 | 2篇 |
1955年 | 2篇 |
排序方式: 共有3819条查询结果,搜索用时 4 毫秒
51.
52.
Fujioka T Aoyama N Sakai K Miwa Y Kudo M Kawashima J Matsubara Y Miwa J Yakabi K 《Journal of gastroenterology》2012,47(3):276-283
Background
In recent years in Japan, the rate of clarithromycin (CAM) resistance in Helicobacter pylori has risen to around 30%, and the eradication rate with triple therapy [proton pump inhibitor + amoxicillin (AMPC) + CAM] has been trending downward to around 70%. In 2007, rabeprazole (RPZ)-based triple therapy (RPZ + AMPC + CAM: RAC therapy) was approved in Japan, and a large-scale nationwide study was therefore initiated to evaluate the efficacy and safety of RAC therapy in clinical practice. 相似文献53.
Sato A Hiroe M Akiyama D Hikita H Nozato T Hoshi T Kimura T Wang Z Sakai S Imanaka-Yoshida K Yoshida T Aonuma K 《Journal of cardiac failure》2012,18(6):480-486
BackgroundTenascin-C (TN-C), an extracellular matrix glycoprotein, is not normally expressed in the adult heart but transiently reappears under various pathologic conditions to play important roles in tissue remodeling. It is unclear whether serum TN-C levels add prognostic information independent from traditional prognostic markers.Methods and ResultsWe assessed 239 patients with first ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention. We measured serum TN-C and plasma B-type natriuretic peptide (BNP) levels on day 5 after admission and compared long-term clinical outcome. During the follow-up period (24.3 ± 13 months), 54 patients experienced primary composite cardiac events (cardiac death or hospitalization for worsening heart failure). Multivariable Cox proportional hazards analysis indicated that serum TN-C (hazard ratio 2.92, 95% confidence interval [CI] 1.55–5.67; P < .001) and plasma BNP levels (hazard ratio 1.84, 95% CI 1.17–2.97; P = .008) were significant independent predictors for cardiac events after adjustment for multiple confounders. The combination of TN-C and BNP resulted in an increase of the c-statistic from 0.821 to 0.877 (P < .001) and an integrated discrimination improvement gain of 14.0% (P < .001).ConclusionsSerum TN-C level on day 5 after admission is potentially useful for early risk stratification after AMI beyond established prognostic markers. 相似文献
54.
Kyoko Ohno-Matsui Pei-Chang Wu Kenji Yamashiro Kritchai Vutipongsatorn Yuxin Fang Chui Ming Gemmy Cheung Timothy Y. Y. Lai Yasushi Ikuno Salomon Yves Cohen Alain Gaudric Jost B. Jonas 《Investigative ophthalmology & visual science》2021,62(5)
Pathologic myopia is a major cause of visual impairment worldwide. Pathologic myopia is distinctly different from high myopia. High myopia is a high degree of myopic refractive error, whereas pathologic myopia is defined by a presence of typical complications in the fundus (posterior staphyloma or myopic maculopathy equal to or more serious than diffuse choroidal atrophy). Pathologic myopia often occurs in eyes with high myopia, however its complications especially posterior staphyloma can also occur in eyes without high myopia.Owing to a recent advance in ocular imaging, an objective and accurate diagnosis of pathologic myopia has become possible. Especially, optical coherence tomography has revealed novel lesions like dome-shaped macula and myopic traction maculopathy. Wide-field optical coherence tomography has succeeded in visualizing the entire extent of large staphylomas. The effectiveness of new therapies for complications have been shown, such as anti-VEGF therapies for myopic macular neovascularization and vitreoretinal surgery for myopic traction maculopathy.Myopia, especially childhood myopia, has been increasing rapidly in the world. In parallel with an increase in myopia, the prevalence of high myopia has also been increasing. However, it remains unclear whether or not pathologic myopia will increase in parallel with an increase of myopia itself. In addition, it has remained unclear whether genes responsible for pathologic myopia are the same as those for myopia in general, or whether pathologic myopia is genetically different from other myopia. 相似文献
55.
Tsunehisa Tsubokawa Syuichi Ishizuka Kyoko Fukumoto Kazuyuki Ueno Ken Yamamoto 《Journal of anesthesia》2013,27(2):243-250
Purpose
Olprinone, a phosphodiesterase type III inhibitor, is a strong inotrope and vasodilator that does not increase oxygen consumption and is often used during weaning from cardiopulmonary bypass (CPB). To control the pharmacological effects of olprinone, pharmacokinetic information is essential; however, there is little published information on the pharmacokinetics of olprinone in a large population. Therefore, the purpose of this study was to determine olprinone pharmacokinetic parameters in a large population undergoing cardiac surgery with CPB.Methods
Olprinone was infused at a rate of 0.2 μg/kg/min when weaning from CPB was started. Whole blood samples were periodically obtained to determine the olprinone concentrations using high-performance liquid chromatography. Measured olprinone concentrations were analyzed with a one-compartment model via a population approach.Results
A total of 86 blood samples from 26 patients were used for pharmacokinetic analysis. The calculated clearance, volume of distribution (V d), and elimination half-life were 378 ml/min, 40.7 l, and 97.1 min, respectively. Olprinone clearance depended on weight and creatinine clearance, whereas V d depended only on weight.Conclusion
We investigated the pharmacokinetic parameters of olprinone in patients undergoing cardiac surgery with CPB. Olprinone clearance depended on weight and creatinine clearance, whereas V d depended only on weight. When olprinone is infused according to the recommended dosing regimen, it takes more than 60 min to reach the target concentration (20 ng/ml). However, there is a possibility that a lower concentration is sufficient for weaning from CPB in combination with a continuous infusion of dopamine. 相似文献56.
Kyoko Satoh Maki Tanaka Ayako Yano Jiang Ying Tatsuyuki Kakuma 《World journal of surgery》2013,37(3):516-524
Background
The St. Gallen consensus provides treatment recommendations for breast cancer based on prognostic factors. Although many patients’ prognostic patterns are not easily matched with the prognostic patterns listed in the St. Gallen consensus, there has been no systematic investigation reporting the gap between treatment recommendations and actual postoperative treatment choices in clinical practice.Methods
Four hundred seventy-one patients with hormone receptor-positive [HR(+)] and human epidermal growth factor receptor type 2-negative [HER2(?)] breast cancer were analyzed. These patients were classified into either the “crisp treatment group” or “fuzzy treatment group” based on the definitiveness of postoperative treatment selection based on St. Gallen treatment recommendations. The patients in the fuzzy treatment group were further classified into strata in which patients within each stratum shared the same prognostic factor patterns with similar recurrence rates.Results
A total of 87.3 % of HR(+)HER2(?) patients were designated to the fuzzy treatment group. Four prognostic strata were constructed according to the survival tree model, and revealed that patients with poor prognostic profiles tended to receive endocrine therapy with chemotherapy. This suggests that postoperative chemotherapy is useful, although there was no statistical significance.Conclusions
We constructed prognostic profiles of patients in the fuzzy treatment group and examined the recurrence rates associated with two treatment regimens within each prognostic profile. These findings are exploratory, but they may be useful for planning prospective studies of the effectiveness of postoperative treatment regimens among patients with a heterogeneous combination of prognostic factors. 相似文献57.
58.
59.
60.
Yokoyama Keitaro Hashimoto Teruo Okuda Yuri Matsumoto Yu Ito Kyoko Yamada Ryoichi Susai Hiroyuki Nishino Noriaki 《Clinical and experimental nephrology》2022,26(7):688-699
Clinical and Experimental Nephrology - Ferric citrate hydrate (FC) is an oral iron-based phosphate binder that is used to treat hyperphosphatemia in patients with chronic kidney disease (CKD). This... 相似文献